User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Autologous bone marrow-derived cell transplantation in decompensated alcoholic liver disease: what is the impact on liver histology and gene expression patterns?

Primary tabs

download
  • Open access
  • PDF
  • 772.82 K
Lanthier, Nicolas [UCL] Lin-Marq, Nathalie Rubbia-Brandt, Laura Clément, Sophie Goossens, Nicolas Spahr, Laurent

BACKGROUND: Liver stem cell therapy (SCT) has been suggested as a promising means to improve liver regeneration in advanced liver disease. However, data from trials are heterogeneous, with no systematic histological evaluation. The aim of this study is to specifically analyze the effect of autologous SCT on liver regeneration and on gene expression changes. METHODS: Individuals in the randomized controlled trial of SCT in alcoholic hepatitis with paired liver biopsies were included (n = 58). Immunohistochemistry (Ki67, K7, and CD68), in situ hybridization (SPINK1), and global gene expression analysis were performed on liver biopsies (30 control patients and 28 patients with transarterial administration of bone marrow-derived stem cells) both at baseline and after 4 weeks of follow-up. RESULTS: No difference between the two groups could be observed regarding the proliferative hepatocyte number, proliferative K7-positive cells, or total K7-positive cells at the 4-week follow-up liver biopsy. However, patients who received SCT showed a more important liver macrophagic expansion as compared to standard treatment. Transcriptome data revealed changes in genes linked with inflammation (CD68 and SAA), regeneration (SPINK1 and HGF), fibrosis (COL1A1), and stem cells (CD45). No changes in gene pathways involved in liver growth and cell cycle proteins were evident. SPINK1 mRNA was present by in situ hybridization at week 4 in SCT patients in the liver parenchyma areas adjacent to macrophage recruitment and liver cell proliferation. CONCLUSIONS: The analysis of liver tissue after SCT demonstrated an expansion of macrophages concurrent with an upregulated expression of genes involved in inflammatory and regenerative pathways. With the negative results from the clinical trial, the impact of the SCT has to be interpreted as weak, and it is not able to modify the clinical course of this severe liver disease.

Document type Article de périodique (Journal article) – Article de recherche
Access type Accès libre
Publication date 2017
Language Anglais
Journal information "Stem Cell Research & Therapy" - Vol. 8, no. 1, p. 88 [1-10] (2017)
Peer reviewed yes
Publisher BioMed Central Ltd. ((United Kingdom) London)
issn 1757-6512
e-issn 1757-6512
Publication status Publié
Affiliations UCL - SSS/IREC/GAEN - Pôle d'Hépato-gastro-entérologie
UCL - (SLuc) Service d'hépato-gastro-entérologie
Keywords Alcoholic hepatitis ; CD68 ; Cirrhosis ; HGF ; Kupffer cell ; Macrophage ; SPINK1 ; Stem cell transplantation
Links
  1. Mathurin Philippe, Therapeutic management of alcoholic hepatitis, 10.1016/j.clinre.2015.05.015
  2. Garg Vishal, Garg Hitendra, Khan Arshi, Trehanpati Nirupama, Kumar Ashish, Sharma Barjesh Chander, Sakhuja Puja, Sarin Shiv Kumar, Granulocyte Colony–Stimulating Factor Mobilizes CD34+ Cells and Improves Survival of Patients With Acute-on-Chronic Liver Failure, 10.1053/j.gastro.2011.11.027
  3. Singh Virendra, Sharma Arun K, Narasimhan R Lakshmi, Bhalla Ashish, Sharma Navneet, Sharma Ratiram, Granulocyte Colony-Stimulating Factor in Severe Alcoholic Hepatitis: A Randomized Pilot Study, 10.1038/ajg.2014.154
  4. Lyra Andre Castro, Soares Milena Botelho Pereira, da Silva Luiz Flavio Maia, Braga Eduardo Lorens, Oliveira Sheilla A., Fortes Marcos Fraga, Silva Andre Goyanna Pinheiro, Brustolim Daniele, Genser Bernd, dos Santos Ricardo Ribeiro, Lyra Luiz Guilherme Costa, Infusion of autologous bone marrow mononuclear cells through hepatic artery results in a short-term improvement of liver function in patients with chronic liver disease: a pilot randomized controlled study : , 10.1097/meg.0b013e32832eb69a
  5. Salama Hosny, Autologous CD34+and CD133+stem cells transplantation in patients with end stage liver disease, 10.3748/wjg.v16.i42.5297
  6. Moore J. K., Stutchfield B. M., Forbes S. J., Systematic review: the effects of autologous stem cell therapy for patients with liver disease, 10.1111/apt.12645
  7. Lanthier N, Rubbia-Brandt L, Spahr L. Liver progenitor cells and therapeutic potential of stem cells in human chronic liver diseases. Acta Gastroenterol Belg. 2013;76:3–9.
  8. Spahr Laurent, Chalandon Yves, Terraz Sylvain, Kindler Vincent, Rubbia-Brandt Laura, Frossard Jean-Louis, Breguet Romain, Lanthier Nicolas, Farina Annarita, Passweg Jakob, Becker Christoph D., Hadengue Antoine, Autologous Bone Marrow Mononuclear Cell Transplantation in Patients with Decompensated Alcoholic Liver Disease: A Randomized Controlled Trial, 10.1371/journal.pone.0053719
  9. Elsegood Caryn L., Chan Chun Wei, Degli-Esposti Mariapia A., Wikstrom Matthew E., Domenichini Alice, Lazarus Kyren, van Rooijen Nico, Ganss Ruth, Olynyk John K., Yeoh George C.T., Kupffer cell-monocyte communication is essential for initiating murine liver progenitor cell-mediated liver regeneration : LIVER INJURY/REGENERATION, 10.1002/hep.27977
  10. Lanthier Nicolas, Rubbia-Brandt Laura, Lin-Marq Nathalie, Clément Sophie, Frossard Jean-Louis, Goossens Nicolas, Hadengue Antoine, Spahr Laurent, Hepatic cell proliferation plays a pivotal role in the prognosis of alcoholic hepatitis, 10.1016/j.jhep.2015.04.003
  11. Viebahn Cornelia S., Benseler Volker, Holz Lauren E., Elsegood Caryn L., Vo Michelle, Bertolino Patrick, Ganss Ruth, Yeoh George C.T., Invading macrophages play a major role in the liver progenitor cell response to chronic liver injury, 10.1016/j.jhep.2010.04.010
  12. , EASL Clinical Practical Guidelines: Management of Alcoholic Liver Disease, 10.1016/j.jhep.2012.04.004
  13. Gilchrist Eleanor S., Plevris John N., Bone marrow-derived stem cells in liver repair: 10 years down the line, 10.1002/lt.21965
  14. Kumar D, Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response, 10.1053/jhep.2002.36370
  15. Bolstad B.M., Irizarry R.A, Astrand M., Speed T.P., A comparison of normalization methods for high density oligonucleotide array data based on variance and bias, 10.1093/bioinformatics/19.2.185
  16. Lanthier Nicolas, Spahr Laurent, SPINK1, macrophages et cellules progénitrices du foie : De nouvelles pistes pour stimuler la régénération dans l’hépatite alcoolique ?, 10.1051/medsci/20163202005
  17. Krohn Natan, Kapoor Sorabh, Enami Yuta, Follenzi Antonia, Bandi Sriram, Joseph Brigid, Gupta Sanjeev, Hepatocyte Transplantation-Induced Liver Inflammation Is Driven by Cytokines-Chemokines Associated With Neutrophils and Kupffer Cells, 10.1053/j.gastro.2009.01.063
  18. Adachi Yukito, Bradford Blair U., Gao Wenshi, Bojes Heidi K., Thurman Ronald G., Inactivation of Kupffer cells prevents early alcohol-induced liver injury, 10.1002/hep.1840200227
  19. Lanthier Nicolas, Targeting Kupffer cells in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Why and how?, 10.4254/wjh.v7.i19.2184
  20. Boulter Luke, Govaere Olivier, Bird Tom G, Radulescu Sorina, Ramachandran Prakash, Pellicoro Antonella, Ridgway Rachel A, Seo Sang Soo, Spee Bart, Van Rooijen Nico, Sansom Owen J, Iredale John P, Lowell Sally, Roskams Tania, Forbes Stuart J, Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease, 10.1038/nm.2667
  21. Van Hul Noémi, Lanthier Nicolas, Español Suñer Regina, Abarca Quinones Jorge, van Rooijen Nico, Leclercq Isabelle, Kupffer Cells Influence Parenchymal Invasion and Phenotypic Orientation, but Not the Proliferation, of Liver Progenitor Cells in a Murine Model of Liver Injury, 10.1016/j.ajpath.2011.06.042
  22. Gao Bin, Tsukamoto Hidekazu, Inflammation in Alcoholic and Nonalcoholic Fatty Liver Disease: Friend or Foe?, 10.1053/j.gastro.2016.01.025
  23. Fang J.W.S., Davis G.L., Lau J.Y.N., Bird G.L.A., Nakamura T., Hepatocyte proliferation as an indicator of outcome in acute alcoholic hepatitis, 10.1016/s0140-6736(94)92025-7
  24. Bihari Chhagan, Anand Lovkesh, Rooge Sheetalnath, Kumar Dhananjay, Saxena Priyanka, Shubham Smriti, Sukriti, Trehanpati Nirupma, Kumar Guresh, Pamecha Viniyendra, Sharma Shvetank, Rastogi Archana, Kumar Anupam, Sarin Shiv K., Bone marrow stem cells and their niche components are adversely affected in advanced cirrhosis of the liver, 10.1002/hep.28754
  25. King A., Barton D., Beard H. A., Than N., Moore J., Corbett C., Thomas J., Guo K., Guha I., Hollyman D., Stocken D., Yap C., Fox R., Forbes S. J., Newsome P. N., REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133+ bone marrow stem cells in patients with cirrhosis. A study protocol for a randomised controlled trial, 10.1136/bmjopen-2015-007700
Bibliographic reference Lanthier, Nicolas ; Lin-Marq, Nathalie ; Rubbia-Brandt, Laura ; Clément, Sophie ; Goossens, Nicolas ; et. al. Autologous bone marrow-derived cell transplantation in decompensated alcoholic liver disease: what is the impact on liver histology and gene expression patterns?. In: Stem Cell Research & Therapy, Vol. 8, no. 1, p. 88 [1-10] (2017)
Permanent URL http://hdl.handle.net/2078.1/185761